Reynolds, Terra

Terra Reynolds

Partner

terra.reynolds@lw.com
    Reynolds, Terra

    Terra Reynolds

    Partner

    terra.reynolds@lw.com
    “She works as though she is two people. She is a force of nature.” “She is very talented in the healthcare and FCA arena and an outstanding investigator.”

    Chambers USA 2022

    “She is experienced, high energy and highly responsive, and has a great command of the facts and details.”

    Chambers USA 2021

    Recognized as one of the world's leading investigations experts 45 or under

    Who's Who Legal: Investigations 2021

    Leading Lawyer – Litigation: White Collar Crime & Government Investigations 

    Chambers USA 2019-2021

    Recommended – Healthcare: Health Issuers, Healthcare: Life Sciences, and Healthcare: Service Providers

    The Legal 500 US 2021

    “She is incredibly hard-working and a strong advocate for her clients.”

    Chambers USA 2020

    Profile

    Terra Reynolds, Global Vice Chair of the Healthcare & Life Sciences Industry Group and Co-Chair of the Chicago Litigation & Trial Department, represents clients in internal and government investigations and complex litigation matters.

    Drawing on more than a decade of experience as a former federal prosecutor, Ms. Reynolds regularly advises corporations, boards of directors, and individual executives on their most sensitive matters involving a range of alleged misconduct. A significant focus of Ms. Reynolds’ work is defending against allegations of healthcare fraud and abuse laws, including the False Claims Act (FCA) and the Anti-Kickback Statute (AKS).

    She frequently handles high-profile investigations brought by the US Department of Justice (DOJ), the US Department of Health and Human Services Office of Inspector General (HHS OIG), the US Food and Drug Administration (FDA), and the Drug Enforcement Administration (DEA).

    Prior to entering private practice, Ms. Reynolds served as an Assistant US Attorney in the Northern District of Illinois, and most recently, as a Deputy Chief. In these roles, she tried more than a dozen federal criminal cases and led numerous investigations. She also briefed and argued matters before the US Court of Appeals for the Seventh Circuit.

    Since entering private practice, Ms. Reynolds has handled dozens of matters on behalf of some of the world’s leading healthcare and life sciences companies and individual executives

    Ms. Reynolds is a member of Latham’s Chicago Women Enriching Business Committee (WEB). Outside of the firm, Ms. Reynolds serves as an adjunct professor of trial advocacy at Northwestern University School of Law. She is also a member of the Board of Directors for Northwestern University School of Law and Legal Aid Chicago.

    Ms. Reynolds clerked for US District Judge Marvin E. Aspen of the US District Court for the Northern District of Illinois.

    Experience

    Ms. Reynolds’ experience includes representing:

    Internal Investigations

    • A medical device company in an internal investigation of sales and marketing practices for compliance with corporate policies and federal regulations
    • A pharmaceutical company in a drug pricing dispute with a national pharmacy chain 
    • A nationwide hospital system and healthcare management company in connection with a series of internal investigations of individual and corporate compliance with policies and federal regulations
    • A physician-owned surgical hospital in connection with an internal investigation of compliance with federal regulations
    • A medical device company in connection with an internal investigation into a cross-border supply chain issue
    • A data analytics company in connection with an internal investigation regarding allegations of financial irregularities and employee misconduct
    • A pharmaceutical company in connection with an internal review of its patient support program*
    • An international tobacco company in connection with a review of whistleblower allegations regarding the compliance of its sales and marketing practices with FDA regulations
    • An international generic manufacturer of opioids in connection with an internal review of its DEA compliance program
    • A multinational pharmaceutical company in preparing a crisis management plan*

    Government Investigations

    • A Covid-19 and genetic testing company in a DOJ criminal healthcare fraud investigation
    • A genetic testing company in a DOJ criminal healthcare fraud investigation
    • A medical device company in a DOJ criminal and civil investigation that resulted in a highly favorable hybrid civil resolution based on civil mistake-of-payment and FCA allegations 
    • A nationwide hospital system in a DOJ FCA investigation, resulting in a declination to intervene and dismissal of the lawsuit
    • A nationwide healthcare management company and a physician-owned surgical hospital in the resolution of an FCA matter involving alleged AKS violations
    • An ambulatory surgery center (ASC) in a DOJ criminal investigation involving allegations of medical necessity and healthcare fraud
    • A nationwide healthcare management company and a physician-owned surgical hospital in the submission of a self-disclosure matter to the HHS-OIG
    • A medical waste management company in a DOJ civil investigation of its historic DEA retail pharmacy business
    • A former medical device company executive in a DOJ civil healthcare fraud investigation, resulting in a declination
    • A medical device sales representative in a DOJ healthcare fraud investigation regarding alleged violations of the FCA and the AKS, resulting in a declination
    • A former union executive in a DOJ criminal investigation into alleged embezzlement of union funds
    • A private equity-backed provider of rehabilitation management services in the resolution of an FCA lawsuit without the imposition of a Corporate Integrity Agreement (CIA)
    • A private equity-backed provider of rehabilitation management services in DOJ healthcare fraud investigations, resulting in declinations to intervene in whistleblower lawsuits
    • A multinational pharmaceutical company in connection with a DOJ investigation into its patient support program, drug pricing, and specialty pharmacy issues*
    • A domestic pharmaceutical company in connection with FDA and DOJ investigations into its sales and marketing practices*

    Litigation

    • A healthcare revenue cycle management company in a non-intervened qui tam lawsuit alleging violations of the FCA and AKS
    • A leading provider of radiology imaging services in a civil racketeering and healthcare fraud lawsuit, resulting in a favorable resolution short of trial
    • An international law firm in a defamation lawsuit, resulting in a dismissal of the complaint that was affirmed on appeal
    • An international law firm in a defamation lawsuit, resulting in a dismissal of the complaint
    • A wrongfully convicted individual in a civil rights lawsuit against the City of Chicago and individual officers
    • A respondent in an International Chamber of Commerce (ICC) arbitration in Singapore concerning allegations of fraud arising from a multibillion-dollar acquisition of an international pharmaceutical company*

    Diligence

    • Private equity investors in prospective healthcare transactions
    • Buyers, sellers, and underwriters in diligence for transactions, including initial public offerings, involving healthcare and life sciences companies

    *Matter handled prior to joining Latham & Watkins

    Qualifications

    Bar Qualification

    • Illinois

    Education

    • JD, Northwestern University Pritzker School of Law, 2002
      Cum Laude
    • BSFS, Georgetown University, 1998

    Practices

    Industries

    Recognition

    News & Insights

    Read More